Luye Pharma Group Ltd. (2186.HK) Stock Competitors & Peer Comparison
See (2186.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2186.HK | HK$2.06 | -7.21% | 8.2B | 11.43 | HK$0.18 | N/A |
| 1093.HK | HK$8.10 | -5.81% | 92.4B | 21.73 | HK$0.37 | +3.58% |
| 1666.HK | HK$3.50 | -2.78% | 4.5B | 9.55 | HK$0.37 | +5.91% |
| 7630.HK | HK$14.01 | -10.76% | 3.9B | -11.30 | -HK$1.24 | N/A |
| 2630.HK | HK$56.60 | -2.41% | 3.8B | -20.96 | -HK$2.70 | N/A |
| 2410.HK | HK$7.33 | -8.83% | 2.8B | -22.30 | -HK$0.33 | N/A |
| 6086.HK | HK$0.81 | -4.71% | 1.1B | -1446.43 | -HK$0.00 | N/A |
| 2563.HK | HK$3.69 | -0.27% | 799.7M | -9.00 | -HK$0.41 | N/A |
| 1643.HK | HK$0.95 | +9.20% | 684M | -47.50 | -HK$0.02 | N/A |
Stock Comparison
2186.HK vs 1093.HK Comparison July 2026
2186.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2186.HK stands at 8.2B. In comparison, 1093.HK has a market cap of 92.4B. Regarding current trading prices, 2186.HK is priced at HK$2.06, while 1093.HK trades at HK$8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2186.HK currently has a P/E ratio of 11.43, whereas 1093.HK's P/E ratio is 21.73. In terms of profitability, 2186.HK's ROE is +0.04%, compared to 1093.HK's ROE of +0.11%. Regarding short-term risk, 2186.HK is less volatile compared to 1093.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2186.HK.Check 1093.HK's competition here